Alnylam Pharmaceuticals (ALNY) and Arrowhead Research Corporation (ARWR) Form Collaboration and Licensing Agreement

1/5/2012 7:05:17 AM

CAMBRIDGE, Mass. & PASADENA, Calif.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Arrowhead Research Corporation, (Nasdaq: ARWR) a nanomedicine company with development programs in RNAi and obesity, announced today that they have entered into a collaboration and joint licensing agreement.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Arrowhead Research Corporation

• Alnylam Pharmaceuticals

• Biotech/Pharma - Alliances